Valeris Sets New Standards in Patient Affordability
Valeris, a prominent player in life sciences commercialization, has made a groundbreaking advance in patient affordability solutions by being the first organization to address the challenges posed by medical benefit maximizers. With a mission to enhance patient access to vital medications, Valeris is steering the conversation towards a critical yet often overlooked aspect within the healthcare landscape.
While many organizations have focused on copay assistance related to pharmacy benefits, the medical benefit realm has seen minimal engagement. This emerging trend of medical benefit maximizers is generating concerns among patients enrolled in plans that incorporate these complex tactics. Valeris aims to rectify this gap by leveraging its advanced technology and industry expertise.
Equipped with its proprietary
Policy Reporter™ technology, the Valeris Patient Affordability team has developed strategies to recognize and disrupt these medical benefit maximizer activities. The technology allows for precise identification of plan administrators and targeted pharmaceuticals, enabling proactive actions against the negative implications of these health plans on affected patients.
Michael Harris, the Vice President of Patient Support Services Strategy at Valeris, expressed, “Our medical benefit copay technology empowers us to identify patients impacted by maximizer plans and allows us to take necessary steps to counteract these challenges before they escalate into more widespread issues.” Valeris has already pinpointed 200 brands threatened by these strategies, showcasing its commitment to supporting patient needs.
As 2026 unfolds, Valeris is gearing up for a year filled with innovative advancements. Initial actions are being implemented and more enhancements are expected to follow, demonstrating Valeris's proactive approach in improving patient experiences. Manufacturers and stakeholders interested in safeguarding their brands from these disruptive tactics are encouraged to reach out to the Valeris Patient Affordability team, who have the tools and insights necessary to navigate this evolving landscape.
Valeris stands at the forefront of life sciences commercialization, aiding over 500 partners in the healthcare sector, and has significantly impacted millions of patients’ lives by enhancing access and affordability for essential medications. They not only focus on commercialization but also offer strategic insights and comprehensive support that traverse the entire healthcare value chain.
The headquarters of Valeris are located in Morrisville, North Carolina, and Jeffersonville, Indiana. To discover more about how Valeris can help revolutionize patient support and navigate the complexities of emerging payer tactics, visit
www.valeris.com.
Valeris is not merely a service provider; it is a dedicated ally in healthcare, committed to dismantling barriers to medication access and championing the needs of patients across the nation, ensuring that quality healthcare is a reality for everyone.